ARCHIVES

FDA Continues Bureaucratic Delays Of Cancer INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 05 | January 30, 1976

Download PDF Visit The Full Archive

Related Articles

ASTRO Issues Statement On APBI For Breast Cancer

August 28, 2009

DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year

May 12, 1978

Sponsors Withdraw Indications for Iressa, Celebrex

February 11, 2011

Advisors suggest NCI establish sarcoma research consortium.

January 30, 2004

Matrisian, Nelson, to lead review of NCI translational research programs.

September 23, 2005

DRCCA Board Cool On communications Network, Hears Report On Behavior Program

May 21, 1982